Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Return to: PBR Home | Contract Research & Services
Today in Contract Research & Services

Contract Research & Services

Incyte treats first patient in clinical trial program for ruxolitinib in GVHD Incyte has treated first patient in the clinical trial program of ruxolitinib (Jakafi) for the treatment of steroid-refractory acute graft-versus-host disease (GVHD). Contract Research & Services > Clinical Trials > News

Latest Contract Research & Services News by Sector

Select a sector from the list or browse by sector below:

Clinical Trials

Sunovion’s dasotraline improves ADHD symptoms in children in phase 2/3 study
By PBR Staff Writer
Sunovion Pharmaceuticals’ novel drug candidate dasotraline has demonstrated significantly improved attention deficit hyperactivity disorder (ADHD) symptoms in children compared to placebo in a phase 2/3 study.
Contract Research & Services > Clinical Trials > News
Novartis to commence phase 2 trial with bimagrumab in obese patients with type 2 diabetes
MorphoSys said its partner Novartis will conduct a phase 2 clinical trial of the HuCAL antibody bimagrumab in obese patients having type 2 diabetes.
Contract Research & Services > Clinical Trials > News

Contract Research

Gilead awards more than $22m in grants to support HIV cure research
US biopharmaceutical firm Gilead Sciences has awarded more than $22m in grants to support 12 new HIV cure research projects.
Contract Research & Services > Contract Research > News
Ipsen to buy Merrimack's global oncology assets
Ipsen has agreed to acquire global oncology assets from Merrimack Pharmaceuticals, including its key marketed product ONIVYDE (irinotecan liposome injection) for the treatment of patients with metastatic adenocarcinoma of the pancreas after disease progression following gemcitabine-based therapy, in combination with fluorouracil and leucovorin.
Contract Research & Services > Contract Research > News

Contract Services

Cumberland Pharmaceuticals, Clinigen sign US commercialization deal for Totect
Cumberland Pharmaceuticals and Clinigen Group have signed an exclusive agreement to commercialize the oncology support drug, Totect (dexrazoxane hydrochloride) in the US.
Contract Research & Services > Contract Services > News
Novartis signs potential $1bn deal with Ionis and Akcea on cardiovascular treatments
By PBR Staff Writer
Novartis has agreed to pay more than $1bn to Ionis Pharmaceuticals and its subsidiary Akcea Therapeutics for the rights to two cardiovascular drugs.
Contract Research & Services > Contract Services > News